Year
Edition number
№20 (333)№s5-16№19 (332)№18 (331)№17 (330)№16 (329)№s4-16№s3-16№15 (328)№14 (327)№13 (326)№12 (325)№11 (324)№10 (323)№9 (322)№8 (321)№6 (319)№5 (318)№4 (317)№3 (316)№s2-16№2 (315)№s1-16№1 (314)
№7 (320) / 2016
V.V. Zakharov
DEPRESSION IN THE ELDERLY AGE6-13
A.N. Barinov (1), K.A. Makhinov (1), D.A. Sergienko (2)
BACK PAIN: NEW TECHNOLOGIES AND OLD PREJUDICES14-21
N.V. Pizova
CHRONIC FATIGUE SYNDROME22-26
V.V. Zakharov, N.V. Vakhnina
NEUROPROTECTIVE THERAPY FOR ACUTE AND CHRONIC CEREBRAL ISCHEMIA27-34
M.I. Kurdina
MONOCLONAL ANTIBODIES IN THE TREATMENT OF PSORIASIS AND PSORIATIC ARTHRITIS35-42
E.S. Akarachkova (1), O.A. Gromova (2), O.V. Kotova (3)
SELECTION OF MODERN SAFE AND EFFECTIVE NSAID IN PATIENTS WITH CONCOMITANT (COMORBID) DISEASES43-48
O.V. Kotova, E.S. Akarachkova
ACUTE LOWER BACK PAIN: THERAPY WITH DRUGS TRAUMEEL S AND SPASCUPREEL49-52
O.F. Gaidukova, A.P. Rebrov, E.V. Khondkaryan, A.V. Aparkina
EFFICACY AND CARDIOVASCULAR SAFETY OF AMTOLMETIN GUACIL IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS: FINAL RESULTS OF KORONA STUDY53-58
O.G. Filimonova, O.V. Simonova
FEATURES QUALITY OF LIFE AND VEGETATIVE STATUS IN PATIENTS WITH PSORIATIC ARTHRITIS AND ANXIETY-DEPRESSIVE DISORDERS59-62
M.M. Kostik, M.F. Dubko, E.A. Isupova, I.A. Chikova, E.A. Gaydar, V. V. Masalova, L.S. Snegireva, O.V. Kalashnikova, V.G. Chasnyk
FACTORS CONTRIBUTING TO THE ACHIEVEMENT OF REMISSION AND DEVELOPMENT OF EXACERBATIONS IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS WITH NO SYSTEMIC MANIFESTATIONS, RECEIVING THERAPY WITH ADALIMUMAB63-70
E.N. Bochanova (1), N.A. Shnayder (1), S.K. Zyryanov (2), D.V. Dmitrenko (1), E.A. Shapovalova (1), O.F. Veselova (1), O.S. Shilkina (1), D.A. Zhuravlev (1)
AGE-RELATED AND GENDER-RELATED ASPECTS OF ADVERSE SIDE EFFECTS IN PATIENTS WITH EPILEPSY AND EPILEPTIC SYNDROMES (ACCORDING TO THE UNIVERSITY CLINIC REGISTER)71-75
V.P. Voloshin (1), S.A. Saravanan (1), A.V. Eremin (1), S.A. Osmakov (1), S.A. Temnov (2), D.V. Semenov (3), K.L. Morkin (4), L.A. Lunev (5)
RESEARCH OF EFFICIENCY OF ACTION OF THE DRUG CHONDROGARD (CHONDROITIN SULPHATE) IN PATIENTS WITH FRACTURES DIFFERENT LOCALIZATION76-79
L.A. Marchenkova
PATHOGENESIS AND TACTICS OF TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS: THE ROLE OF ALFACALCIDOL80-85
E.S. Akarachkova (1), L.R. Kadyrova (2), O.V. Kotova (1)
MAGNESIUM DEFICIENCY AS A CAUSE AND A CONSEQUENCE OF OSTEOPOROSIS86-91
E.N. Bochanova (1), N.A. Shnayder (1), S.K. Zyryanov (2), D.V. Dmitrenko (1), D.A. Zhuravlev (1), K.G. Nozdrachev (1), V.V. Bogdanov (1), O.F. Veselova (1)
EVALUATION OF CONSUMPTION OF ANTIEPILEPTIC DRUGS IN OUTPATIENT PRACTICE IN KRASNOYARSK REGION92-95
